The Drug Life Cycle Compliance Consultant Service Department of AUSTAR was founded in 2000. It has numerous senior GxP experts of the pharmaceutical industry around the globe and cooperates with several famous consulting institutes outside China. Our mission is to help our clients to achieve operation excellence in the highly competitive business environments by improving the regulatory compliance and obtaining sustainable competitive advantages. Guided by the latest regulations and guidelines around the globe, the services of the department are centered on the pharmaceutical quality system and dedicated in providing GxP compliance services meeting FDA, EMA, CFDA, MHRA, PIC/S and WHO requirements throughout the product life cycle for the pharmaceutical industry through our strong project management and execution team, experienced overseas consultants and experts and the complete validation instruments imported from EU and the US. Up to now, we have successfully serviced hundreds of pharmaceutical enterprises. Adhering to the customer satisfaction oriented concept, AUSTAR provides compliance consultancy services covering the entire product life cycle in such aspects as QbD based research and development and clinical study quality system consultancy services, technology transfer management consultancy services, ICH Q10 based pharmaceutical quality system consultancy services, commissioning and verification technical services, intelligent system planning technical services, lean production consultancy services, etc. AUSTAR has been developed into a global company dedicated in providing consultancy services to our pharmaceutical clients adopting scientific principles and risk analysis approaches.